ATE323176T1 - DETECTION OF BREAST TUMOR VIRUS-LIKE SEQUENCES IN HUMAN BREAST CANCER - Google Patents

DETECTION OF BREAST TUMOR VIRUS-LIKE SEQUENCES IN HUMAN BREAST CANCER

Info

Publication number
ATE323176T1
ATE323176T1 AT96943485T AT96943485T ATE323176T1 AT E323176 T1 ATE323176 T1 AT E323176T1 AT 96943485 T AT96943485 T AT 96943485T AT 96943485 T AT96943485 T AT 96943485T AT E323176 T1 ATE323176 T1 AT E323176T1
Authority
AT
Austria
Prior art keywords
breast cancer
sequences
detection
tumor virus
human
Prior art date
Application number
AT96943485T
Other languages
German (de)
Inventor
James F Holland
Beatriz G T Pogo
Original Assignee
James F Holland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James F Holland filed Critical James F Holland
Application granted granted Critical
Publication of ATE323176T1 publication Critical patent/ATE323176T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to materials and methods for diagnosing breast cancer in humans. It is based, at least in part, on the discovery that a substantial percentage of human breast cancer tissue samples contained nucleic acid sequences corresponding to a portion of the mouse mammary tumor env gene. In contrast, such sequences were absent in almost all other human tissues tested.
AT96943485T 1995-11-09 1996-11-08 DETECTION OF BREAST TUMOR VIRUS-LIKE SEQUENCES IN HUMAN BREAST CANCER ATE323176T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/555,394 US5686247A (en) 1995-11-09 1995-11-09 Detection of mammary tumor virus env gene-like sequences in human breast cancer

Publications (1)

Publication Number Publication Date
ATE323176T1 true ATE323176T1 (en) 2006-04-15

Family

ID=24217097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943485T ATE323176T1 (en) 1995-11-09 1996-11-08 DETECTION OF BREAST TUMOR VIRUS-LIKE SEQUENCES IN HUMAN BREAST CANCER

Country Status (8)

Country Link
US (2) US5686247A (en)
EP (1) EP0866878B1 (en)
JP (1) JP2000500650A (en)
AT (1) ATE323176T1 (en)
AU (1) AU717291B2 (en)
CA (1) CA2236837C (en)
DE (1) DE69636041T2 (en)
WO (1) WO1997017470A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040176314A1 (en) * 1997-07-07 2004-09-09 Bio Merieux Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
WO1999004265A2 (en) * 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
CA2328181A1 (en) * 1998-04-08 1999-10-14 International Bioimmune Systems, Inc. Immunomodulatory compositions of mmtv antigens and methods of using same
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
HK1046535B (en) 1999-06-30 2009-02-27 The Administrators Of The Tulane Educational Fund Human endogenous retrovirus
WO2005073728A1 (en) * 2004-01-29 2005-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for diagnosing and treatment of breast cancer and pharmaceuticals copmsition and kit for same
US8093063B2 (en) * 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707438A (en) * 1984-08-22 1987-11-17 Tel Aviv University Immunoassay for breast cancer employing monoclonal antibodies

Also Published As

Publication number Publication date
EP0866878A1 (en) 1998-09-30
EP0866878B1 (en) 2006-04-12
CA2236837C (en) 2009-01-27
DE69636041D1 (en) 2006-05-24
WO1997017470A1 (en) 1997-05-15
EP0866878A4 (en) 2002-02-13
CA2236837A1 (en) 1997-05-15
AU717291B2 (en) 2000-03-23
AU1271497A (en) 1997-05-29
US6040146A (en) 2000-03-21
JP2000500650A (en) 2000-01-25
US5686247A (en) 1997-11-11
DE69636041T2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
ATE353974T1 (en) METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER
DE69938662D1 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
EP1870466A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
DE59705683D1 (en) IMMUNOLOGICAL DETECTION METHOD OF ANTIBODIES TARGETED AGAINST TISSUE TRANSGLUTAMINASE (tTG), USE OF tTG FOR DIAGNOSIS AND THERAPY CONTROL, AND ORAL PHARMACEUTICAL AGENT CONTAINING tTG
ATE223051T1 (en) METHOD FOR DIAGNOSIS OF BENCNIC PROSTATE DISEASES
TR200201567T2 (en) Active fluorescent contrast agent and fluorescence imaging in the near infrared light region.
SE8902532D0 (en) DETERMINATION OF PLASMA PROTEINS
MX9604183A (en) A screening method for identifying ligands for target proteins.
ATE323176T1 (en) DETECTION OF BREAST TUMOR VIRUS-LIKE SEQUENCES IN HUMAN BREAST CANCER
DE60114018D1 (en) CELLS PRESENTED PEPTIDES
DE69605908D1 (en) USE OF REAGENTS DERIVED FROM THE HUMAN METASTASE REPRESENTATION GENE KAI1 IN DIAGNOSTIC AND GENE-TERAPEUTIC PROCEDURES
DE60044350D1 (en) PROSTATE SPECIFIC GEN PCGEM1 AND METHODS OF USE FOR THE RECOGNITION, TREATMENT AND PREVENTION OF PROSTATE CANCER
EA200000845A1 (en) GENE ENCODING NEW CANCER MARKER
ATE126599T1 (en) METHOD FOR DETERMINING ANTI-RNS ANTIBODIES.
NO963487L (en) Isolated tyrosinase-derived peptides, and uses thereof
GB9710154D0 (en) Detection of retroviruses
DE69827805D1 (en) METHOD AND DEVICE FOR DETERMINING THE TRANSFORMATION POTENTIAL OF CONNECTIONS.
ATE406178T1 (en) PREVENTION OF IMMUNOREACTIVITY THROUGH DEPUPPERATION OR INHIBITION OF ANTIGEN-PRESENTING CELLS
DE69823660D1 (en) METHOD FOR IDENTIFYING TUMORANTIGENS WITH AUTOANTIBODIES IN SERUM
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
DE68929511D1 (en) Detection, quantification and classification of RAS proteins in body fluids and tissues
IT1283899B1 (en) PEPTIDES AND THEIR USES IN THE CELIAC DISEASE THERAPY
DE69433787D1 (en) PEPTIDES DERIVED FROM HTLV-I AND HTLV-II GP21 FOR DIAGNOSTIC USE
DE69628659D1 (en) METHOD FOR DETERMINING BLOOD CREATION FACTORS VIII AND IX
DE50015355D1 (en) PROTEIN MTR1 RELATED TO TRP PROTEINS AND THIS CODING DNA SEQUENCE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties